Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chien

Showing results (511-520 of 550) with videos related to

Pageof 55
Sort By:
Leukemia Research|February 21, 2023
PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemiaAlex Bataller, Kelly S Chien, Koji Sasaki, et al.
Leukemia|April 2, 2025
Clinicopathologic characteristics and outcomes of patients with clonal hematopoiesis who progress to myeloid neoplasmsKelly S Chien, Julie S Braish, Ziyi Li, et al.
Cancer Medicine|March 18, 2024
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasmsKelly S Chien, Faustine Ong, Kunhwa Kim, et al.
International Journal of Clinical Practice|May 18, 2006
Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: a retrospective studyC-H Lee, I-K Wang, T-C Chen, et al.
Leukemia & Lymphoma|February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agentsKelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.
Biology|January 21, 2023
Concurrent Mutations in <i>SF3B1</i> and <i>PHF6</i> in Myeloid NeoplasmsZhuang Zuo, L Jeffrey Medeiros, Sofia Garces, et al.
British Journal of Cancer|August 6, 2014
In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cellsP Jiang, R Mukthavaram, Y Chao, et al.
Leukemia & Lymphoma|September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemiaYue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Experimental Hematology|September 23, 2022
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaFaezeh Darbaniyan, Hong Zheng, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 31, 2021
Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Faezeh Darbaniyan, Rashmi Kanagal-Shamanna, et al.
Pageof 55

Showing results (511-520 of 550) with videos related to

Sort By:
Pageof 55
Leukemia Research|February 21, 2023
PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemiaAlex Bataller, Kelly S Chien, Koji Sasaki, et al.
Leukemia|April 2, 2025
Clinicopathologic characteristics and outcomes of patients with clonal hematopoiesis who progress to myeloid neoplasmsKelly S Chien, Julie S Braish, Ziyi Li, et al.
Cancer Medicine|March 18, 2024
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasmsKelly S Chien, Faustine Ong, Kunhwa Kim, et al.
International Journal of Clinical Practice|May 18, 2006
Anticardiolipin antibodies and vascular access thrombosis in Taiwanese haemodialysis patients with chronic hepatitis C: a retrospective studyC-H Lee, I-K Wang, T-C Chen, et al.
Leukemia & Lymphoma|February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agentsKelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.
Biology|January 21, 2023
Concurrent Mutations in <i>SF3B1</i> and <i>PHF6</i> in Myeloid NeoplasmsZhuang Zuo, L Jeffrey Medeiros, Sofia Garces, et al.
British Journal of Cancer|August 6, 2014
In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cellsP Jiang, R Mukthavaram, Y Chao, et al.
Leukemia & Lymphoma|September 5, 2022
MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemiaYue Wei, Hong Zheng, Pamela Pennington Lockyer, et al.
Experimental Hematology|September 23, 2022
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaFaezeh Darbaniyan, Hong Zheng, Rashmi Kanagal-Shamanna, et al.
Leukemia Research|January 31, 2021
Type I interferon upregulation and deregulation of genes involved in monopoiesis in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Faezeh Darbaniyan, Rashmi Kanagal-Shamanna, et al.
Pageof 55